¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"target response"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
anamnestic response
¸é¿ª±â¾ï¹ÝÀÀ
biologic response modifier
»ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦, »ýü¹ÝÀÀÁ¶Àý¹°Áú
biological response modifier
»ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦, »ýü¹ÝÀÀÁ¶Àý¹°Áú
brain stem evoked response audiometry
³úÁÙ±âÀ¯¹ß¹ÝÀÀû·Â°Ë»ç
concentration-response curve
³óµµ¹ÝÀÀ°î¼±
conditioned response
Á¶°Ç¹ÝÀÀ
consummatory response
¼ºÃë¹ÝÀÀ
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
chemotactic response
ÈÇÐÁÖ¼º¹ÝÀÀ, ÈÇнò¸²¹ÝÀÀ
dose-response curve
¿ë·®¹ÝÀÀ°î¼±
dose-response relationship
¿ë·®¹ÝÀÀ°ü°è
evoked response
À¯¹ß¹ÝÀÀ
evoked response audiometry
À¯¹ß¹ÝÀÀû·Â°Ë»ç
frequency response curve
Á֯ļö¹ÝÀÀ°î¼±
galvanic skin response
Àü±âÇǺιÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
alerting response
°¢¼º¹ÝÀÀ
anamnestic response
(¢¡secondary immune response) ÀÌÂ÷¸é¿ª¹ÝÀÀ
arousal response
°¢¼º¹ÝÀÀ
autoimmune response
ÀÚ°¡¸é¿ª¹ÝÀÀ
brainstem evoked response audiometry
³úÁÙ±âÀ¯¹ß¹ÝÀÀû·Â°Ë»ç
evoked response audiometry
À¯¹ß¹ÝÀÀû·Â°Ë»ç
galvanic skin response audiometry
ÇǺÎÀü±â¹ÝÀÀû·Â°Ë»ç
startle response audiometry
³î¶÷¹ÝÀÀû·Â°Ë»ç
stimulus response assessment
ÀڱعÝÀÀÆò°¡
biologic response modifier
»ýü¹ÝÀÀÁ¶Àý¹°Áú, »ý¹°ÇÐÀû¹ÝÀÀÁ¶ÀýÁ¦
bulbocavernous evoked-response test
¸Á¿ïÇØ¸éü±ÙÀ¯µµ¹ÝÀÀ°Ë»ç
response bias
¹ÝÀÀ¹ÙÀ̾
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
chemotactic response
ÈÇÐÁÖ¼º¹ÝÀÀ, ÈÇнò¸²¹ÝÀÀ
concentration-response curve
³óµµ¹ÝÀÀ°î¼±
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
galvanic skin response =GSR
Àü±âÇǺιÝÀÀ(ï³Ñ¨ù«Ý±Úãëë).
galvanic skin response audiometry
ÇǺÎÀü±â¹ÝÀÀ û·Â°Ë»ç
heat shock response
¿Ãæ°Ý¹ÝÀÀ
ideosyncratic drug response
ƯÀ̼º ¾à¹° ¹ÝÀÀ
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ª¹ÝÀÀ
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ªÀÀ´ä.
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
immune response, primary
ÀÏÂ÷¸é¿ª¹ÝÀÀ
immune response, secondary
ÀÌÂ÷¸é¿ª¹ÝÀÀ
immunologic response
¸é¿ª¹ÝÀÀ.
immunological response
¸é¿ªÇÐÀû¹ÝÀÀ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
source-target distance, STD
¼±¿øÇ¥Àû°£°Å¸®
target
Ç¥Àû(øöîÜ)
target cell
Ç¥Àû¼¼Æ÷
target cell anemia
Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
target cell anemia
Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
target configuration
°ú³á ¸ð¾ç (Ç¥Àû¸ð¾ç)
target configuration
°ú³á ¸ð¾ç (Ù¼åÆ)
target glands
Ç¥Àû¼±(øöîÜàÍ).
target lesion
Ç¥Àû º´º¯
target lesions
Ç¥Àûº´¼Ò, °ú³áº´¼Ò, ŸÄÉÆ®º´¼Ò
target organ
Ç¥ÀûÀå±â
target pattern
°ú³á ¾ç»ó
target sign
°ú³á ¡ÈÄ
target skin distance radiation
Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
target skin distance=TSD
Ç¥ÀûÇǺΰŸ®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½